MSLN and ovarian carcinoma: In addition to mesothelioma, C-ERC/mesothelin is also expressed in ovarian cancer (4,10), pancreatic ductal adenocarcinoma (8,11,12), breast cancer (13), colorectal cancer (14) and esophageal adenocarcinoma (15).